138 related articles for article (PubMed ID: 9376348)
1. Extracellular cysteines of the corticotropin-releasing factor receptor are critical for ligand interaction.
Qi LJ; Leung AT; Xiong Y; Marx KA; Abou-Samra AB
Biochemistry; 1997 Oct; 36(41):12442-8. PubMed ID: 9376348
[TBL] [Abstract][Full Text] [Related]
2. Impact of N-terminal domains for corticotropin-releasing factor (CRF) receptor-ligand interactions.
Klose J; Fechner K; Beyermann M; Krause E; Wendt N; Bienert M; Rudolph R; Rothemund S
Biochemistry; 2005 Feb; 44(5):1614-23. PubMed ID: 15683245
[TBL] [Abstract][Full Text] [Related]
3. Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues critical for peptide binding.
Gkountelias K; Tselios T; Venihaki M; Deraos G; Lazaridis I; Rassouli O; Gravanis A; Liapakis G
Mol Pharmacol; 2009 Apr; 75(4):793-800. PubMed ID: 19124613
[TBL] [Abstract][Full Text] [Related]
4. The three-dimensional structure of the N-terminal domain of corticotropin-releasing factor receptors: sushi domains and the B1 family of G protein-coupled receptors.
Perrin MH; Grace CR; Riek R; Vale WW
Ann N Y Acad Sci; 2006 Jul; 1070():105-19. PubMed ID: 16888152
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides.
Behan DP; De Souza EB; Lowry PJ; Potter E; Sawchenko P; Vale WW
Front Neuroendocrinol; 1995 Oct; 16(4):362-82. PubMed ID: 8557170
[TBL] [Abstract][Full Text] [Related]
6. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
Frändberg PA; Doufexis M; Kapas S; Chhajlani V
Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
[TBL] [Abstract][Full Text] [Related]
7. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
Hoare SR; Sullivan SK; Schwarz DA; Ling N; Vale WW; Crowe PD; Grigoriadis DE
Biochemistry; 2004 Apr; 43(13):3996-4011. PubMed ID: 15049707
[TBL] [Abstract][Full Text] [Related]
8. Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.
Dautzenberg FM; Wille S
Regul Pept; 2004 May; 118(3):165-73. PubMed ID: 15003833
[TBL] [Abstract][Full Text] [Related]
9. Photoaffinity cross-linking of the corticotropin-releasing factor receptor type 1 with photoreactive urocortin analogues.
Kraetke O; Holeran B; Berger H; Escher E; Bienert M; Beyermann M
Biochemistry; 2005 Nov; 44(47):15569-77. PubMed ID: 16300406
[TBL] [Abstract][Full Text] [Related]
10. Cloning and characterization of a short variant of the corticotropin-releasing factor receptor subtype from rat amygdala.
Miyata I; Shiota C; Ikeda Y; Oshida Y; Chaki S; Okuyama S; Inagami T
Biochem Biophys Res Commun; 1999 Mar; 256(3):692-6. PubMed ID: 10080961
[TBL] [Abstract][Full Text] [Related]
11. [¹²⁵I]YP20: a novel radioligand specific for the extracellular domain of the CRF₁ receptor.
Gordon JC; Edwards P; Elmore CS; Lazor LA; Paschetto K; Bostwick R; Sylvester M; Mauger R; Scott C; Aharony D
Eur J Pharmacol; 2010 Dec; 649(1-3):59-63. PubMed ID: 20854803
[TBL] [Abstract][Full Text] [Related]
12. A variant of the human corticotropin-releasing factor (CRF) receptor: cloning, expression and pharmacology.
Ross PC; Kostas CM; Ramabhadran TV
Biochem Biophys Res Commun; 1994 Dec; 205(3):1836-42. PubMed ID: 7811272
[TBL] [Abstract][Full Text] [Related]
13. Monkey corticotropin-releasing factor1 receptor: Complementary DNA cloning and pharmacological characterization.
Oshida Y; Ikeda Y; Chaki S; Okuyama S
Life Sci; 2004 Feb; 74(15):1911-24. PubMed ID: 14761672
[TBL] [Abstract][Full Text] [Related]
14. An intramolecular disulfide bond between conserved extracellular cysteines in the gonadotropin-releasing hormone receptor is essential for binding and activation.
Cook JV; Eidne KA
Endocrinology; 1997 Jul; 138(7):2800-6. PubMed ID: 9202220
[TBL] [Abstract][Full Text] [Related]
15. Hexa-histidin tag position influences disulfide structure but not binding behavior of in vitro folded N-terminal domain of rat corticotropin-releasing factor receptor type 2a.
Klose J; Wendt N; Kubald S; Krause E; Fechner K; Beyermann M; Bienert M; Rudolph R; Rothemund S
Protein Sci; 2004 Sep; 13(9):2470-5. PubMed ID: 15295109
[TBL] [Abstract][Full Text] [Related]
16. Allosteric ligands for the corticotropin releasing factor type 1 receptor modulate conformational states involved in receptor activation.
Hoare SR; Fleck BA; Gross RS; Crowe PD; Williams JP; Grigoriadis DE
Mol Pharmacol; 2008 May; 73(5):1371-80. PubMed ID: 18239030
[TBL] [Abstract][Full Text] [Related]
17. A disulfide bonding interaction role for cysteines in the extracellular domain of the thyrotropin-releasing hormone receptor.
Cook JV; McGregor A; Lee T; Milligan G; Eidne KA
Endocrinology; 1996 Jul; 137(7):2851-8. PubMed ID: 8770906
[TBL] [Abstract][Full Text] [Related]
18. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
Hoare SR; Sullivan SK; Fan J; Khongsaly K; Grigoriadis DE
Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653
[TBL] [Abstract][Full Text] [Related]
19. The functional role of cysteines adjacent to the NRY motif of the human MT1 melatonin receptor.
Kokkola T; Salo OM; Poso A; Laitinen JT
J Pineal Res; 2005 Aug; 39(1):1-11. PubMed ID: 15978051
[TBL] [Abstract][Full Text] [Related]
20. Localization and characterization of a short isoform of the corticotropin-releasing factor receptor type 2alpha (CRF(2)alpha-tr) in the rat brain.
Miyata I; Shiota C; Chaki S; Okuyama S; Inagami T
Biochem Biophys Res Commun; 2001 Jan; 280(2):553-7. PubMed ID: 11162554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
